Generative AI just bypassed decades of traditional chemistry to design a viable antibiotic from scratch, but the real test lies in the clinical pipeline.
Smartwatches and rings are marketed as lifesaving heart monitors, but new data shows their single-lead AI systems fail the very patients who need them most.
A massive data breach at Novo Nordisk reveals that the real value of modern pharma is no longer just the chemical formula, but the digital infrastructure behind it.
A new deep-learning model diagnoses autoimmune hepatitis with expert-level accuracy in some scenarios, but its failure against hepatitis B reveals a critical diagnostic blind spot.
A new reanalysis reveals that highly praised machine learning survival models underperform both human doctors and a thirty-year-old statistical formula at predicting patient death at critical clinical milestones.